Stock Track | Chemed Stock Plunges as Q3 Earnings Miss Estimates

Stock Track10-30

Shares of Chemed Corporation (CHE) took a significant hit on Tuesday, plummeting by 5.71% as the company reported its third-quarter financial results for the period ended September 30, 2024. The stock's decline came in response to the company's weaker-than-expected earnings and revenue figures.

Chemed reported adjusted earnings per share (EPS) of $5.64 for the quarter, missing analysts' consensus estimate of $5.76. The company's revenue rose 7.4% year-over-year to $606.18 million, but it fell short of Wall Street's expectations of $612.22 million.

Despite the earnings miss, Chemed reported a quarterly net income of $75.78 million. However, investors appeared to be disappointed with the company's performance, as evidenced by the stock's sharp decline following the earnings release.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment